SO
BCAX

STRS Ohio’s Bicara Therapeutics BCAX Stock Holding History

STRS Ohio’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$145K Buy
+4,900
New +$109K ﹤0.01% 1732
2025
Q1 		– Sell
-3,600
Closed -$62.7K – 2034
2024
Q4 		$62.7K Buy
+3,600
New +$74.9K ﹤0.01% 1699

Other funds holding BCAX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RTM
Red Tree Management Redwood City, California $147M AUM 202.18% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

STRS Ohio's BCAX Position: Q2 2026 in Review

STRS Ohio opened a new position in Bicara Therapeutics (BCAX) in Q2 2026: 4,900 shares worth $145K. The stake represents ﹤0.01% of the portfolio and ranks #1732 among its holdings. This is a return to the name: STRS Ohio previously reported a position in BCAX as recently as Q4 2024.

STRS Ohio first reported a position in BCAX in Q4 2024 and has held it in 2 quarters since. 171 funds tracked by Wall St. Rank hold BCAX as of Q2 2026.

  • STRS Ohio held 4,900 shares of Bicara Therapeutics worth $145K as of Q2 2026.
  • Bicara Therapeutics was a new STRS Ohio position in Q2 2026.
  • Bicara Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1732 holding.
  • STRS Ohio first reported a position in Bicara Therapeutics in Q4 2024 and has held it in 2 quarters since.
  • 171 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.